BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12828718)

  • 41. Natural history of false-negative papanicolaou smears: a prospective study using screening colposcopy in addition to cytology.
    Mannino JR
    J Am Osteopath Assoc; 1998 Oct; 98(10):542-6. PubMed ID: 9821735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy.
    van der Marel J; van Baars R; Rodriguez A; Quint WG; van de Sandt MM; Berkhof J; Schiffman M; Torné A; Ordi J; Jenkins D; Verheijen RH; Helmerhorst TJ; Ter Harmsel B; Wentzensen N; Del Pino M
    Gynecol Oncol; 2014 Nov; 135(2):201-7. PubMed ID: 25204846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective parallel randomized trial of the MultiCyte™ ThinPrep(®) imaging system: the Scottish experience.
    Palmer TJ; Nicoll SM; McKean ME; Park AJ; Bishop D; Baker L; Imrie JE
    Cytopathology; 2013 Aug; 24(4):235-45. PubMed ID: 22616770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colposcopic management of high-grade referral smears: a retrospective audit supporting 'see and treat'?
    Errington CA; Roberts M; Tindle P; Michael E; Bulmer JN; Wadehra V
    Cytopathology; 2006 Dec; 17(6):339-47. PubMed ID: 17168916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Qualifying the cytologic diagnosis of "atypical squamous cells of undetermined significance" affects the predictive value of a squamous intraepithelial lesion on subsequent biopsy.
    Genest DR; Dean B; Lee KR; Sheets E; Crum CP; Cibas ES
    Arch Pathol Lab Med; 1998 Apr; 122(4):338-41. PubMed ID: 9648902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
    Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE
    Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trends in the frequency and predictive value of reporting high grade abnormalities in cervical smears.
    Sparkes J; Schoolland M; Barrett P; Kurinczuk JJ; Mitchell KM; Sterrett GF
    Cancer; 2000 Aug; 90(4):215-21. PubMed ID: 10966561
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome analysis of 4 years' follow-up of patients referred for colposcopy with one smear showing mild dyskaryosis.
    Ahmed AS; Goumalatsos G; Akbar N; Lawton FG; Savvas M
    Cytopathology; 2008 Apr; 19(2):94-105. PubMed ID: 17937774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.
    Szarewski A; Mesher D; Cadman L; Austin J; Ashdown-Barr L; Ho L; Terry G; Liddle S; Young M; Stoler M; McCarthy J; Wright C; Bergeron C; Soutter WP; Lyons D; Cuzick J
    J Clin Microbiol; 2012 Jun; 50(6):1867-73. PubMed ID: 22422852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cervical glandular neoplasia referrals and the diagnosis of adenocarcinoma in situ: Correlating cytology, colposcopy findings, and clinical outcomes.
    Nikolopoulos M; Athanasias P; Godfrey MAL; Nikolopoulos K; Maheshwari MK
    Cytopathology; 2021 Nov; 32(6):751-757. PubMed ID: 34181788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
    Kaufman RH; Adam E; Icenogle J; Reeves WC
    Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
    Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quality metrics in cervical cytopathology: A single institutional study.
    Senthil Kumar D; Ravikumar G
    Cytopathology; 2022 Mar; 33(2):230-235. PubMed ID: 34854153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Triage of women with atypical squamous cells of undetermined significance (ASC-US): results of an Italian multicentric study.
    Del Mistro A; Frayle-Salamanca H; Trevisan R; Matteucci M; Pinarello A; Zambenedetti P; Buoso R; Fantin GP; Zorzi M; Minucci D
    Gynecol Oncol; 2010 Apr; 117(1):77-81. PubMed ID: 20116836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A retrospective analysis of 94 patients with CIN and false negative cervical smears taken at colposcopy.
    Beeby AR; Wadehra V; Keating PJ; Wagstaff TI
    Cytopathology; 1993; 4(6):331-7. PubMed ID: 8110972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study.
    Nobbenhuis MA; Walboomers JM; Helmerhorst TJ; Rozendaal L; Remmink AJ; Risse EK; van der Linden HC; Voorhorst FJ; Kenemans P; Meijer CJ
    Lancet; 1999 Jul; 354(9172):20-5. PubMed ID: 10406360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
    Arbyn M; Buntinx F; Van Ranst M; Paraskevaidis E; Martin-Hirsch P; Dillner J
    J Natl Cancer Inst; 2004 Feb; 96(4):280-93. PubMed ID: 14970277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Negative cervical smears before CIN 3/carcinoma. Reevaluation with the PAPNET Testing System.
    Doornewaard H; van de Seijp H; Woudt JM; van der Graaf Y; van den Tweel JG
    Acta Cytol; 1997; 41(1):74-8. PubMed ID: 9022729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of a control quality strategy in cervical cytology.
    Gullo CE; Dami AL; Barbosa AP; Marques AM; Palmejani MA; de Lima LG; Bonilha JL
    Einstein (Sao Paulo); 2012; 10(1):86-91. PubMed ID: 23045833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.